BPC-157 Research Quality

Research Overview

BPC-157 has been studied for over 30 years, primarily by Croatian researchers. The research base includes extensive animal studies but very limited human data.

Strengths of Current Research

• Extensive Animal Data: Hundreds of studies in rodents and other animals
• Multiple Applications: Studied across diverse conditions and tissues
• Mechanistic Studies: Growing understanding of how it works
• Consistent Findings: Many studies show similar beneficial effects

Research Limitations

Major Gaps

• Limited Human Studies: Only 2-3 small human trials published
• No Large Clinical Trials: No Phase III trials conducted
• Single Research Group: Most studies from one Croatian team
• No Long-term Data: Effects of chronic use unknown
• Publication Bias: Negative results may not be published

What's Needed

For BPC-157 to gain regulatory approval and clinical acceptance:

• Large-scale randomized controlled trials in humans
• Long-term safety studies
• Replication by independent research groups
• Standardized dosing protocols
• Pharmacokinetic studies in humans